0001522767-23-000036.txt : 20230314 0001522767-23-000036.hdr.sgml : 20230314 20230314164215 ACCESSION NUMBER: 0001522767-23-000036 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230307 FILED AS OF DATE: 20230314 DATE AS OF CHANGE: 20230314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Villare Susan M. CENTRAL INDEX KEY: 0001677293 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54433 FILM NUMBER: 23731625 MAIL ADDRESS: STREET 1: C/O MARIMED INC. STREET 2: 10 OCEANA WAY CITY: NORWOOD STATE: MA ZIP: 02062 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MARIMED INC. CENTRAL INDEX KEY: 0001522767 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 274672745 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 OCEANA WAY STREET 2: 2ND FLOOR CITY: NORWOOD STATE: MA ZIP: 02062 BUSINESS PHONE: 617-795-5940 MAIL ADDRESS: STREET 1: 10 OCEANA WAY STREET 2: 2ND FLOOR CITY: NORWOOD STATE: MA ZIP: 02062 FORMER COMPANY: FORMER CONFORMED NAME: WORLDS ONLINE INC. DATE OF NAME CHANGE: 20110608 4 1 wf-form4_167882652294396.xml FORM 4 X0306 4 2023-03-07 0 0001522767 MARIMED INC. MRMD 0001677293 Villare Susan M. C/O MARIMED INC. 10 OCEANA WAY NORWOOD MA 02062 0 1 0 0 Chief Financial Officer Common stock 350000 D Restricted Stock Units (RSU) 2023-03-07 4 A 0 60000 0 A Common Stock, par value $.001 per share 60000.0 60000 D Option to buy common stock 0.64 2027-05-02 Common Stock, par value $.001 per share 400000.0 400000 D The RSUs were granted to the Reporting Person in accordance with Rule 16b-3(d) of the Securities Exchange Act of 1934, as amended. Each RSU represents a contingent right to receive one share of the Issuers common stock RSUs convert to common stock on a one-for-one basis. The RSUs vest over a three year period of which 20,000 RSUs will vest on March 7, 2024 and thereafter, 10,000 RSUs will vest every succeeding six (6) months through March 7, 2026, on each of September 7th and March 7th, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. Granted to the Reporting Person on May 2, 2022 (the "Grant Date"), this option is exercisable to acquire 100,000 of the underlying shares on the six (6) month anniversary of the Grant Date (the "Initial Vesting Date") and for an additional 100,000 shares on the last day of every succeeding six (6) month period after the Initial Vesting Date until the option is fully vested. /s/ Susan M. Villare 2023-03-13